Fact CheckerSign in

NCT07228052RecruitingPhase 4

Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department

Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department: A Randomized Control Trial

Source: ClinicalTrials.gov · Last updated 24 Jul 2026

Brief summary (registry, in English)

This study aims to compare the efficacy of a one-time IM dose of dexamethasone versus a 5-day course of prednisone in adult ED patients presenting with asthma exacerbations. This is a randomized, controlled, double-blind, non-inferiority trial conducted at two urban EDs within the Montefiore Health System.

Status (registry)
Recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
182 (estimated)
First submitted
12 Nov 2025
Start date
Jul 2026
Primary completion date
Dec 2026
Lead sponsor
Montefiore Medical Center
Diseases
Asthma
NCT number
NCT07228052

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 182
  • From Jul 2026 to the primary completion date, Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Current use of systemic corticosteroids, including Emergency Medical Services (EMS) administration before ED arrival

Other illness

  • History of severe adverse reactions to corticosteroids

Lab values

  • Heart failure and uncontrolled diabetes (glucose \>300mg/dL in the ED)

Other

  • Pregnancy or breastfeeding as prednisone is the preferred treatment for asthma in this population
  • Inability to provide informed consent

Who the study is looking for

  • Adults ≥18 years old presenting to the ED with an asthma exacerbation
  • Diagnosed with asthma per International Classification of Diseases, 10th Revision (ICD-10) criteria or by the treating clinician
  • Discharged from the ED with a primary diagnosis of asthma exacerbation
  • Initiated systemic corticosteroids during the ED visit
  • Must be English or Spanish speaking

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Montefiore Medical Center
Coordinator of this site? Confirm its status
The BronxUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.